Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today
rare diseases
Pharma
EU regulators offer post-mortem of Tavneos withdrawal decision
EU regulators have outlined concerns that led to last week's formal revocation of the marketing authorization for the rare-disease med Tavneos.
Fraiser Kansteiner
Aug 14, 2026 11:04am
Neurocrine's Prader-Willi med tied to possible safety concerns
Aug 13, 2026 9:40am
Leo Pharma gears up for GPP awareness day
Aug 13, 2026 2:00am
BridgeBio’s Attruby cruises toward blockbuster land
Aug 11, 2026 11:22am
Amgen doesn't think Repatha's sales wins will stop anytime soon
Aug 4, 2026 4:01pm
Amylyx demystifies post-bariatric hypoglycemia
Jul 31, 2026 2:17pm
